Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

KOVE Medical, a Zurich-based MedTech startup, secures €1.7 million to develop an innovative implantable device aimed at reducing preterm birth risks. The funding was backed by a syndicate of angel investors.

PRIVATEAug 31, 20263 days ago

Amount Raised

€1.7 Million

Round Type

Seed

ZurichBiotechnologyHealth CareMedicalMedical Device

Investors

Angel Investors

Description

KOVE Medical has closed a €1.7 million funding round to advance its development of an implantable medical device designed to reduce preterm birth risks. The fresh capital will support the company as it progresses towards First-in-Human studies. This funding round was backed by a syndicate of angel investors. KOVE Medical aims to address critical complications associated with fetoscopy.

Company Information

Company

KOVE Medical

Location

Zurich, Zurich, Switzerland

About

KOVE Medical is a MedTech startup focused on developing an implantable medical device aimed at reducing the risk of preterm birth following foetal surgery. Founded in 2020, the company emerged from research connected to the University of Zurich and University Hospital Zurich. Their device addresses complications associated with fetoscopy by stabilising the foetal membrane after surgical procedures. KOVE Medical aims to enhance the safety and effectiveness of prenatal interventions for serious conditions affecting babies before birth.

Don't miss KOVE Medical's next move

Get an email the moment KOVE Medical raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for KOVE Medical's next move

See what Strategic adds

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

KOVE Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.